跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 63,734 条关于
“Mucopolysaccharidosis Type II”
全部
63,734
临床试验
54,354
药物
817
机构
59
资讯
8,504
2年前
JCR Pharmaceuticals' JR-441 Receives Clearance for Phase I MPS IIIA Trial in Japan
去年
REGENXBIO Presents ABBV-RGX-314 Data for Wet AMD and Diabetic Retinopathy at AAO 2024
2年前
JCR Pharmaceuticals' Laronidase for Hurler Syndrome Expected to Generate $38M by 2040
去年
FDA Grants Orphan Drug Designation to JR-446 for Rare Neurological Disorder MPS IIIB
去年
2024 Breakthroughs and Setbacks in Lysosomal Disorder Gene Therapies
去年
Ultragenyx's UX111 Gene Therapy Shows Promise in Sanfilippo Syndrome Type A
去年
Advancements in Gene and Cell Therapies Target Diverse Diseases
2个月前
Children's Wisconsin Becomes First U.S. Hospital to Administer AVLAYAH, a Blood-Brain Barrier-Crossing Enzyme Replacement Therapy for Hunter Syndrome
去年
JCR Pharmaceuticals Completes Enrollment in Global Phase III Trial for Blood-Brain Barrier-Penetrating Hunter Syndrome Therapy
5天前
MEDIPAL and JCR Dose First Patient in Global Phase I/II Trial of JR-446 for Sanfilippo Syndrome Type B
第 1 页，共 851 页
上一页
下一页
